Skip to main content
SpringerLink
Log in

Intensivtherapie des Myokardinfarktes — Limitierung der Infarktgröße

  • Conference paper
Verhandlungen der Deutschen Gesellschaft für Innere Medizin

Part of the book series: Verhandlungen der Deutschen Gesellschaft für Innere Medizin ((VDGINNERE,volume 95))

  • 38 Accesses

Zusammenfassung

Der akute Myokardinfarkt gehört mit der instabilen Angina pectoris und dem plötzlichen Herztod zu den drei akuten Koronarsyndromen, die sich nur im Ausmaß und der Geschwindigkeit der Thrombusentstehung unterscheiden [16]. Ein solcher Koronarverschluß (Abb. 1) führt zu einem akuten Ausfall der Myokardperfusion und innerhalb weniger Sekunden zum Ausfall der Funktion des nicht mehr perfundierten Myokards. Wird das Gefäß innerhalb weniger Minuten wieder geöffnet [34, 37, 38, 48], erholt sich das Myokard vollständig. Bleibt die Durchblutung längere Zeit blockiert, entwickelt sich ein Infarkt, der von subendokardial nach epikardial sich ausbreitet [24, 46, 47, 52, 53]. t bedeutet eine kurze Ischämie mit Ausbildung einer Innenschichtischämie oder, wie man heute sagt, eines Non-Q-Infarktes, eine längere Ischämiezeit eine transmurale Infarzierung mit Ausbildung eines sog. Q-Wellen-Infarktes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. AIMS Trial Study Group (1988) Wirkung von intravenösem APSAC auf die Letalität nach akutem Myokardinfarkt: vorläufiger Bericht über eine Placebo-kontrollierte klinische Prüning. Lancet II:441–446

    Google Scholar 

  2. Basinski A, Naylor CD (1988) Aspirin and Fibrinolysis. Lancet II:1188–1189

    Article  Google Scholar 

  3. Braunwald E (1988) Thrombolytic Therapy of acute myocardial infarction : resolved and unresolved issues. J Am Coll Cardiol 12:85A–92A

    Article  PubMed  CAS  Google Scholar 

  4. Chesebro JH, Knatterad G, Roberts R, Borer J, Cohen S, Dalen J, Francis CK, Hillis D, et al. (1987) Thrombolysis in myocardial infarction (TIMI) trial: phase I. Circulation 76:142–154

    Article  PubMed  CAS  Google Scholar 

  5. Erbel R, Meinertz Th, Wessler I, Meyer J, Seybold-Epting W (1984) Recanalization of occluded left main coronary artery in unstable angina pectoris. Am J Cardiol 53:1725

    Article  PubMed  CAS  Google Scholar 

  6. Erbel R, Pop T, v Olshausen K, Treese N, Henrichs KJ, Schuster CJ, Rupprecht HJ, Schlürmann W, Meyer J (1988) Combination of calcium channel blocker and thrombolytic therapy in acute myocardial infarction. Am Heart J 115:529

    Article  PubMed  CAS  Google Scholar 

  7. Erbel R, Pop T, Henrichs KJ, v Olshausen K, Schuster CJ, Rupprecht HJ, Steuernagel C, Meyer J (1986) Percutaneous transluminal coronary angioplasty after thrombolytic therapy. A prospective controlled randomized trial. J Am Coll Cardiol 8:485

    Article  PubMed  CAS  Google Scholar 

  8. Erbel R, Pop T, Diefenbach Ch, Meyer J (1989) Long-term results of thrombolytic therapy with and without percutaneous transluminal coronary angioplasty. J Am Coll Cardiol (in press)

    Google Scholar 

  9. Erbel R, Pop T, Meyer J (1987) Neue Strategien bei der Behandlung des akuten Myokardinfarktes in der präklinischen Phase im Hinblick auf Lyse, Koronarographie und PTCA. Intensivmedizin und Notfallmedizin 24:41–45

    Google Scholar 

  10. Erbel R, Pop T, Meyer J (1988) PTCA nach Thrombolyse beim akuten Myokardinfarkt. Z Kardiol 77 [Suppl 4]:37–42

    PubMed  Google Scholar 

  11. Erbel R, Meyer J (1988) Akuter Myokardinfarkt. In: Schuster HP, Schölmerich P, Schönborn H, Baum PP (Hrsg) Intensivmedizin. Thieme, Stuttgart, S 358–397

    Google Scholar 

  12. Erbel R, Schatz R, Dietz U, Nixdorff U, Haude M, Aichinger S, Pop T, Meyer J (1989) Angioplastie — Valvuloplastie. Z Kardiol 78:71–77

    PubMed  CAS  Google Scholar 

  13. Feldman R (1987) An overview of the use of coronary angioplasty in the treatment of the patient with evolving acute myocardial infarction. J Am Coll Cardiol:9–14

    Google Scholar 

  14. Franzosi MG, Mauri F, Pampallona S, Bossi M, Matta F, Farina ML, Tognoni G (1987) The GISSI Study: further analysis. Circulation 76 [Suppl II]:52–56

    Google Scholar 

  15. Garabedian HD, Gold HK, Yasuda T, Johns JA, Finkelstein DM, Gaivin RJ, et al. (1988) Detection of coronary artery reperfusion with creatine kinase MB determination during thrombolytic therapy: correlation with acute angiography. J Am Coll Cardiol 11:729

    Article  PubMed  CAS  Google Scholar 

  16. Gorlin R, Fuster V, Ambrose JA (1986) Anatomic-physiologic links between acute coronary syndromes. Circulation 74:6

    Article  PubMed  CAS  Google Scholar 

  17. Gruppo Italiano Per Lo Studio Delia Streptochinasi Nell Infarto Myocardio (GISSI) (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet I:397

    Google Scholar 

  18. Gruppo Italiano Per Lo Studio della Streptochinasi Nell Infarto Myocardio (GISSI) (1987) Effectiveness of intravenous thrombolytic therapy in acute myocardial infarction. Final report of the GISSI Study. Lancet II:871–874

    Google Scholar 

  19. Guerci A, Gerstenblith G, Brinker JA, Chandra NC, Gottlieb SO, Bahr RD, Weiss JL, Shapiro EP, et al. (1987) A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty. N Engl J Med 317:1613–1617

    Article  PubMed  CAS  Google Scholar 

  20. Hammermeister KE, De Rouen TA, Dogde HT (1979) Variables predictive of survival in patients with coronary disease. Circulation 59:421–430

    PubMed  CAS  Google Scholar 

  21. Henning H, Gilpin E, Covell J, Swan EA, O’Rourke RA, Ross Jr J (1979) Prognosis after acute myocardial infarction. A multivariate analysis of mortality and survival. Circulation 59:1124–1135

    PubMed  CAS  Google Scholar 

  22. Hochman JS, Choo H (1987) Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 75:299–306

    Article  PubMed  CAS  Google Scholar 

  23. Honan MB, Harrell FE, Reimer KA, Mark OB, Pryor DB, Hlatky MA (1988) Cardiac rupture and timing of thrombolytic therapy: A meta-analysis. Circulation 78 [Suppl II]:503

    Google Scholar 

  24. Hopkins J, Savage M, Zalewski A, Dervan JP, Goldberg SH (1988) Recurrent ischemia in the zone of prior myocardial infarction: Results of coronary angioplasty of the infarct-related artery. Am Heart J 115:14–19

    Article  PubMed  CAS  Google Scholar 

  25. ISAM Study Group (1986) A prospective trial of intravenous streptokinase in myocardial infarction. N Engl J Med 314:1465

    Article  Google Scholar 

  26. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction. ISIS 2. J Am Coll Cardiol 12:3A–13A

    Article  Google Scholar 

  27. Kennedy JW, Ritchie JL, Davis B, Fritz JK (1983) Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med 309:1477

    Article  PubMed  CAS  Google Scholar 

  28. Kennedy JW, Martin GV, Davis KB, Maynard CH, Stadius M, Sheehan F, Ritchie JL (1988) The Western Washington intravenous Streptokinase in acute myocardial infarction. Randomized trial. Circulation 77:345–352

    Article  PubMed  CAS  Google Scholar 

  29. Klein HH, Schubothe M, Nebendahl KL, Kreuzer H (1984) Temporal and spatial development of myocardial infarcts in porcine hearts without significant collateral blood flow. Tex Heart Inst J 11:154–159

    PubMed  CAS  Google Scholar 

  30. Van der Laarse A, Vermeer F, Hermens WT, Willems GM, de Neef K, Simoons ML, et al. (1986) Effects of early intracoronary streptokinase on infarct size estimated from cumulative enzyme release and on enzyme release rate: A randomized trial of 533 patients with acute myocardial infarction. Am Heart J 112:672–681

    Article  PubMed  Google Scholar 

  31. Lee L, Erbel T, Brown T, Laufer N, Suhy P, O’Neill WW (1987) Multicenter registry of angioplasty therapy of cardiogenic shock, initial and long term survival. Circulation 76 [Suppl II]:261

    Google Scholar 

  32. Leibhoff RH, Schwartz H (1989) Clinical sequelae: special patients subsets, incomplete occlusion of the infarct-related artery and coronary collaterals. Circulation 76 [Suppl II]:25–30

    Google Scholar 

  33. Löwel H, Lewis M, Keil U, Koenig W, Hörrmann A, Bolte HD, Gostomzyk J (1988) Zur Herzinfarktsituation in einer süddeutschen Bevölkerung: Ergebnisse des Augsburger Herzinfarkt-registers 1985. Z Kardiol 77:481–489

    PubMed  Google Scholar 

  34. Mathey DG, Kuck KH, Tilsner V, Krebber HJ, Bleifeld W (1981) Nonsurgical coronary artery recanalization in acute transmural myocardial infarction. Circulation 63:489

    Article  PubMed  CAS  Google Scholar 

  35. Mathey DG, Schofer J, Sheehan F, Krebber HJ, Justen M, Rodewald G, et al. (1988) Improved survival up to four years after early coronary thrombolysis. Am J Cardiol 61:524–529

    Article  PubMed  CAS  Google Scholar 

  36. Meyer J, Merx W, Schmitz H, Erbel R, Kieslich T, Dörr R, et al. (1982) Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation 66:905

    Article  PubMed  CAS  Google Scholar 

  37. Neuhaus KL, Tebbe U, Sauer G, Kreuzer H, Köstering H (1983) High dose intravenous streptokinase in acute myocardial infarction. Clin Cardiol 6:426–434

    Article  PubMed  CAS  Google Scholar 

  38. Neuhaus KL, Tebbe U, Gottwik M, Weber MA, Feuerer W, Niederer W, Haerer W, et al. (1988) Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS). J Am Coll Cardiol 12:581–587

    PubMed  CAS  Google Scholar 

  39. Nixdorff U, Erbel R, Pop T, Henrichs KJ, Beck F, Meyer J (1988) ST-segment analysis for prediction of „salvaged myocardium“ after thrombolysis in acute myocardial infarction. Eur Heart J 9 [Suppl I]: 10

    Google Scholar 

  40. Nixdorff U, Erbel R, Pop T, Henrichs KJ, Meyer J (1989) Langzeitverlauf der thrombolytischen Therapie des akuten Myokardinfarktes mit und ohne PTCA. Z Kardiol (im Druck)

    Google Scholar 

  41. Patel B, Kloner R (1987) Analysis of reported randomized trials of streptokinase therapy for acute myocardial infarction in the 1980s. Am J Cardiol 59:501–504

    Article  PubMed  CAS  Google Scholar 

  42. Pfeffer M, Lamas GA, Vaughan DE, Parisi AF, Braunwald E (1988) Effect of captopril of progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 319:80–86

    Article  PubMed  CAS  Google Scholar 

  43. Pop T, Erbel R, Treese N, v Olshausen K, Meyer J (1987) Häufigkeit und Art von Reperfusionsarrhythmien bei der thrombolytischen Therapie des akuten Myokardinfarktes. Z Kardiol 76:81

    PubMed  CAS  Google Scholar 

  44. O’Neill W, Erbel R, Laufer N, Walton J, Bates E, Topol E, Bourdillon D, Meyer J, Pitt B (1985) Coronary angioplasty therapy of cardiogenic shock complicating acute myocardial infarction. Circulation 72 [Suppl III]:309

    Google Scholar 

  45. O’Neill W, Topol EJ, Fung A, Bourdillon PV, Nicklas JM, Walton J, Bates ER, Pitt B (1987) Coronary angioplasty as therapy for acute myocardial infarction: University of Michigan experience. Circulation 76 [Supply II]:79–87

    Google Scholar 

  46. Reimer KA, Lowe JE, Rasmussen M, Jennings RB (1977) The „Wavefront phenomenon“ of ischemic cell death. I. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 56:786–794

    PubMed  CAS  Google Scholar 

  47. Reimer KA, Jennings RB (1979) The „wavefront phenomenon“ of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 40:633–644

    PubMed  CAS  Google Scholar 

  48. Rentrop P, Blanke H, Karsch KR, Kaiser H, Köstering H, Leitz K (1982) Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 63:307

    Article  Google Scholar 

  49. Ritchie JL, Cerqueira M, Maynard C, Davis K, Kennedy JW (1988) Ventricular function and infarct size: The Western Washington intravenous streptokinase in myocardial infarction trial. J Am Coll Cardiol 11:689–697

    Article  PubMed  CAS  Google Scholar 

  50. Rodewald G, Mathey D, Krebber HJ (1985) Bypass surgery following thrombolytic therapy. Z Kardiol 74 [Suppl 6]:143–146

    PubMed  Google Scholar 

  51. Schaer DH, Ross AM, Wassermann AG (1987) Reinfarction, recurrent angina and reocclusion after thrombolytic therapy. Circulation 76 [Suppl II]: 57–62

    Google Scholar 

  52. Schaper J (1986) Ultrastructural aspects of ischemia and reperfusion in canine and human heart. In: Effert S, v Essen R (eds) Thrombolysis. Facts and Hopes. Steinkopff, Darmstadt, S 1

    Google Scholar 

  53. Schaper W (1983) Pathophysiologie der Koronarinsuffizienz. In: Köhler E, Noack E, Schrey A, Weiß M (Hrsg) Mononitrat. Wolf, München, S 66

    Google Scholar 

  54. Schmidt SB, Varghese PJ, Bloom S, et al. (1986) The influence of residual coronary stenosis in size of infarction after reperfusion in a canin preparation. Circulation 73:1354–1359

    Article  PubMed  CAS  Google Scholar 

  55. Serruys PW, Suryapranata H, Simoons L, Vermeer F, Van den Brand M, De Feyter PJ, et al. (1987) Intracoronary thrombolysis in patients with acute myocardial infarction: The Netherlands randomized trial and current status. Circulation 76 [Suppl II]:63–78

    Google Scholar 

  56. Sharpe N, Murphy J, Smith H, Hannan S (1988) Behandlung von Patienten mit asymptomatischer linksventrikulärer Funktionsstörung nach Myokardinfarkt. Lancet II:452–456

    Google Scholar 

  57. Simoons ML, Betriua A, Col J, von Essen R, Lubsen J, et al. (1988) Thrombolysis with tissue plasminogen acitvator in acute myocardial infarction: No additional benefit from immediate percutaneous coronary angioplasty. Lancet I:197–202

    Article  Google Scholar 

  58. Simoons ML, Serruys PW, Van den Brand M, Res J, Freek WA, Verheugt A, Krauss H, et al. (1986) Early thrombolysis in acute myocardial infarction: limitations of infarct size and improved survival. J Am Coll Cardiol 7:717–728

    Article  PubMed  CAS  Google Scholar 

  59. Tomota H (1988) Experimental study on myocardial salvage by coronary thrombolysis and mechanical recanalization. Am Heart J 116:687–695

    Article  Google Scholar 

  60. Topol E, Califf RM, George BS, Kereiakes DJ, Abbottsmith ChW, et al. (1987) A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 317:581–587

    Article  PubMed  CAS  Google Scholar 

  61. Turpie AG, Robinson JG, Doyle DJ, Mulji A, Mishkei J, et al. (1989) Comparison of high-dose with lowdose subcutaneous heparin to prevent left ventricular mural thrombolysis in patients with acute transmural anterior myocardial infarction. N Engl J Med 320:352–357

    Article  PubMed  CAS  Google Scholar 

  62. Uraizee A, Reimer KA, Murry ChE, Jennings EB (1987) Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs. Circulation 75:1237–1428

    Article  PubMed  CAS  Google Scholar 

  63. Van de Werf F (1988) Lessons from the European Cooperative recombinant tissue-type plasminogen activator (rt-PA) versus placebo trial. J Am Coll Cardiol 12:14A–19A

    Article  PubMed  Google Scholar 

  64. White HD, Rivers JT, Maslowski AH, Ormito JA, Takayama M, Hart HH, Sharpe N, Whitloch RML, Norris EM (1987) Effect of intravenous streptokinase compared with tissue-type plasminogen activator or left ventricular function after first myocardial infarction. N Engl J Med 317:850–855

    Article  PubMed  CAS  Google Scholar 

  65. Yusuf S, Wittes J, Friedman L (1988) Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA 260:288–293

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. II. Medizinische Klinik und Poliklinik, Johannes Gutenberg-Universität Mainz, Deutschland

    R. Erbel, U. Nixdorff, M. Haude, E. Goerge, N. Treese, K. J. Henrichs, T. Pop, C. Diefenbach & J. Meyer

Authors
  1. R. Erbel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Nixdorff
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Haude
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Goerge
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Treese
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. J. Henrichs
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. Pop
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. Diefenbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J. Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Humboldtstr. 14, Wiesbaden, D-6200, Deutschland

    Klaus Miehlke

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag, Berlin Heidelberg

About this paper

Cite this paper

Erbel, R. et al. (1989). Intensivtherapie des Myokardinfarktes — Limitierung der Infarktgröße. In: Miehlke, K. (eds) Verhandlungen der Deutschen Gesellschaft für Innere Medizin. Verhandlungen der Deutschen Gesellschaft für Innere Medizin, vol 95. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83864-4_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83864-4_35

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-51437-4

  • Online ISBN: 978-3-642-83864-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation